Fri, Jul 11, 2014, 6:02 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • deepdeepdeepthroat deepdeepdeepthroat Sep 3, 2013 11:00 AM Flag

    HEB is perpetually "upgrading" its Alferon manufacturing

    But never seems to successfully manufacture any Alferon to the FDA's standards.

    "Philadelphia, PA, Wednesday, May 21, 2003: Hemispherx Biopharma, Inc. (AMEX: HEB) today announced that it has accelerated several production steps in the manufacturing of its lead compound, Alferon N, to target the fulfillment of anticipated orders. These decisions have been taken to meet the changing goals of technology acceleration, manufacturing agility, equipment productivity targets and time-to-market requirements.

    “We are pleased to have reached the point of full insight into important factors affecting the manufacturing enabling us to accelerate the process, which brings us ahead of our initial schedule and which should further increase productivity and cost-effectiveness,” said Dr. William A. Carter, CEO of Hemispherx.

    ...Some types of HPV are well established to be the cause of cervical cancer and recent research suggest HPV to be associated with the Vulvar Vestibulitis Syndrome (VVS). Vulvar vestibulitis, a type of vulvodynia, affects many American women. Patients typically present with a history of intermittent or continuous, localized, vulvar pain and frequently cannot tolerate sexual intercourse."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Carter sounds like the pointy-haired boss in Dilbert here:

      “We are pleased to have reached the point of full insight into important factors affecting the manufacturing enabling us to accelerate the process, which brings us ahead of our initial schedule and which should further increase productivity and cost-effectiveness,” said Dr. William A. Carter, CEO of Hemispherx.

 
HEB
0.2972+0.0072(+2.48%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.